0001104659-21-032065.txt : 20210304 0001104659-21-032065.hdr.sgml : 20210304 20210304150840 ACCESSION NUMBER: 0001104659-21-032065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDREWS RONALD ASBURY CENTRAL INDEX KEY: 0001299153 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36439 FILM NUMBER: 21713843 MAIL ADDRESS: STREET 1: 5791 VAN ALLEN WAY CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER NAME: FORMER CONFORMED NAME: Andrews Ronald Asbury DATE OF NAME CHANGE: 20040730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Precipio, Inc. CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 203 787 7888 MAIL ADDRESS: STREET 1: 4 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: TRANSGENOMIC INC DATE OF NAME CHANGE: 20000119 4 1 tm215617d2_4.xml OWNERSHIP DOCUMENT X0306 4 2021-03-01 0 0001043961 Precipio, Inc. PRPO 0001299153 ANDREWS RONALD ASBURY C/O PRECIPIO, INC., 4 SCIENCE PARK NEW HAVEN CT 06511 1 0 0 0 Employee Stock Option (right to buy) 2.60 2021-03-01 4 A 0 2069 0 A 2031-03-01 Common Stock 2069 2069 D Employee Stock Option (right to buy) 2.60 2021-03-01 4 A 0 5171 0 A 2031-03-01 Common Stock 5171 5.171 D On March 1, 2021 (the "Effective Date"), Mr. Ron A. Andrews (the "Reporting Person") was appointed to the Board of Directors of Precipio, Inc. (the "Company"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an "Option" and together, the "Options") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date). The Option vests in twelve equal monthly installments beginning on the Effective Date. The Option vests in thirty-six equal monthly installments beginning on the Effective Date. /s/ Ron A Andrews 2021-03-04